Integration of SciLog Platforms into Xcellerex FlexFactory
Delivers on Promise of TurnKey SingleUse Solutions for Bioprocess Management
Middleton, Wisconsin based Scilog, a global supplier and innovator of bioprocess management solutions for critical downstream applications and Xcellerex, a global supplier of singleuse turnkey solutions for biomanufacturing and bioprocessing, have announced the successful integration of SciLog products into the Xcellerex FlexFactory® Biomanufacturing Platform.
The successful integration of SciLog’s SciFlex® and SciPure® platforms into the Xcellerex FlexFactory Biomanufacturing platform to deliver downstream protein purification will be on display at Interphex in the Xcellerex Booth (#1813). This proven integration delivers on the promise of turnkey singleuse solutions for biomanufacturing and bioprocess management and the associated advantages.
Hans Schick, V.P. of Business Development for SciLog, Inc. “The integration SciLog has achieved with the next generation FlexFactory platform from Xcellerex has allowed us to deliver on the promise of singleuse solutions for biomanufacturing and bioprocess management from the Upstream through to the Downstream applications.”
To learn more, contact Hans Schick, V. P. of Business Development, hs@scilog.com or (608)8240500 Office or (608)2174077 (mobile). Visit SciLog’s InterPhex Booth (#1051) which will showcase SciLog’s singleuse sensors, manifolds and purification platforms.
About SciLog, Inc.
SciLog, Inc. is a private, closely held company. For the past 20 years, SciLog has been a major innovator in downstream applications and products in the biotech/pharma industry and has licensed several of its patents to companies such as GE Health Care. SciLog holds numerous US patents, Canadian, EU and rest of world patents concerning automation of downstream processing, singleuse sensors and singleuse manifolds in a wide variety of applications. For more information, please visit SciLog’s website https://www.scilog.com for complete product descriptions and upcoming show schedule.
About Xcellerex, Inc.
The company’s unique singleuse component technology platform transforms biomanufacturing economics, enabling the development of biotherapeutics and vaccines, and dramatically improving the ability of Xcellerex and its partners to deploy manufacturing capacity. Xcellerex leverages its technology and services platform by: 1) commercializing its FlexFactories® (complete, turnkey, modular production trains) and XDR (unique, single use component bioreactor systems); 2) building a portfolio of proprietary biotherapeutics and vaccines through creative alliances and in licensing; and 3) creatively structuring transactions around FlexFactories, XDRs and its pipeline. Based in Marlborough, Massachusetts, Xcellerex is backed by an experienced management team and toptier venture investors including Kleiner Perkins Caufield & Byers, VantagePoint Venture Partners and SCG Capital.
